All In MedTech

Company

PROCEPT BioRobotics

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

PROCEPT BioRobotics is on our public-company list (ticker PRCT). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

PRCT

Nasdaq · PROCEPT BioRobotics Corp

Public float

$3.20B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$308M

Fiscal year ending Dec 31, 2025

Net income

-$95.6M

Fiscal year ending Dec 31, 2025

R&D spending

$71.3M

Fiscal year ending Dec 31, 2025

Cash

$218M

As of Sep 30, 2026

Long-term debt

$51.8M

As of Sep 30, 2026

Shares outstanding

57.5M

As of Oct 29, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2024–$165M––
2023–$162M––
2021$172M–––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jun 10, 2021Equity$85.0M$85.0M50Rule 506(b)Form D ↗Jun 21, 2021
Jul 30, 2020Equity$77.0M$77.0M17Rule 506(b)Form D ↗Aug 14, 2020
Feb 15, 2018Equity$118M$118M54Rule 506(b)Form D ↗Mar 1, 2018

4 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
PROCEPT BioRobotics Corp
Headquarters
Redwood City, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    11 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For PROCEPT BioRobotics we have 3 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    The 8 newest of 9 since 2015.

    Search the Clearance Tracker

    6 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • WATER IV PCa (AS Sub-study)Pivotal-lookingRecruiting

      NCT07650448 · 333 participants (planned) · Start Sep 11, 2026 · Primary completion Dec 2028

      Device: Aquablation Therapy · For: Localized Prostate Cancer

      Sites: Chandler, Arizona; Los Angeles, California; Murrieta, California · 28 sites in all

    • WATER IV Prostate CancerPivotal-lookingActive, not recruiting

      NCT06651632 · 280 participants (planned) · Start Feb 3, 2025 · Primary completion Jul 2027

      Device: Aquablation Therapy · For: Localized Prostate Cancer

      Sites: Chandler, Arizona; Mesa, Arizona; Los Angeles, California · 37 sites in all

    • NCT06051942 · 125 participants · Start Nov 22, 2022 · Primary completion Jul 2026

      Device: Robotic Waterjet Treatment · For: Benign Prostatic Hyperplasia; Localized Prostate Cancer

      Sites: La Mesa, California; Glenview, Illinois; Alexandria, Virginia · 6 sites in all

    8 more trials with a free account

    Reports received

    244

    Received Nov 1, 2025 to Nov 20, 2026. Includes 3 of another or unstated type.

    Malfunction reports

    81

    33% of reports

    Injury reports

    149

    61% of reports

    Death reports

    11

    4.5% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 23201500
    Jan 2410800
    Feb 24111500
    Mar 24262410
    Apr 2471000
    May 24141200
    Jun 2414810
    Jul 24122210
    Aug 2417830
    Sep 247700
    Oct 2481010
    Nov 24121140
    Dec 24131200
    Jan 2552200
    Feb 25201400
    Mar 25302110
    Apr 2581400
    May 2571300
    Jun 25161100
    Jul 25121400
    Aug 2531000
    Sep 2511900
    Oct 2591010
    Nov 254510
    Dec 2551510
    Jan 2611710
    Feb 2651110
    Mar 26102000
    Apr 2662330
    May 263720
    Jun 2671700
    Jul 2661401
    Aug 26111401
    Sep 267810
    Oct 266811
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    3 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.